JPS57112331A - Medical composition of ganoderma lucidum component - Google Patents
Medical composition of ganoderma lucidum componentInfo
- Publication number
- JPS57112331A JPS57112331A JP55187752A JP18775280A JPS57112331A JP S57112331 A JPS57112331 A JP S57112331A JP 55187752 A JP55187752 A JP 55187752A JP 18775280 A JP18775280 A JP 18775280A JP S57112331 A JPS57112331 A JP S57112331A
- Authority
- JP
- Japan
- Prior art keywords
- thrombosis
- ganoderma lucidum
- hypertension
- reagent
- positive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
PURPOSE: The titled composition useful for remedying and preventing symptomes complices of thrombosis in the blood, having low toxicity, obtained by subjecting a fruit body of ganoderma lucidum to thermal extraction with water, removing unsoluble components from the extracted solution, followed by concentration and drying.
CONSTITUTION: The titled composition comprising a medicinal component of ganoderma lucidum as an active ingredient. The medical component has the following chemical and physical properties. The maximum absorptions of infrared spectrum (KBr method) are about 3,450, 2,970, 1,700, 1,460, 1,390, and 1,040cm-1; the maximum absorption of ultraviolet spectrum is about 257W258nm; positive in Fehling's reagent, quasipositive in phenylhydrazine reagent, and positive in ninhydrine reaction. This medicinal component is known to have extremely improved effect on hypertension, hyperlipemia and arteriosclerosis, and effective for against a group of diseases, symptomes complices of thrombosis in the blood vessel, spread in a wide range, caused by the formation of thrombosis in the blood vessel, especially thrombosis with hypertension. An oral dose is 10W 300mg/time, and 2W3 times a day.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55187752A JPS57112331A (en) | 1980-12-29 | 1980-12-29 | Medical composition of ganoderma lucidum component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55187752A JPS57112331A (en) | 1980-12-29 | 1980-12-29 | Medical composition of ganoderma lucidum component |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57112331A true JPS57112331A (en) | 1982-07-13 |
JPH0148249B2 JPH0148249B2 (en) | 1989-10-18 |
Family
ID=16211574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55187752A Granted JPS57112331A (en) | 1980-12-29 | 1980-12-29 | Medical composition of ganoderma lucidum component |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57112331A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60184025A (en) * | 1984-03-02 | 1985-09-19 | Toyo Yakushiyoku Kogyo Kk | Polysaccharide, separation and use thereof |
JP2005162627A (en) * | 2003-11-28 | 2005-06-23 | Nippon Menaade Keshohin Kk | Medicinal composition of ingredient of ganoderma atrum, ganoderma japonicum, ganoderma sinense or the like |
JP2005298391A (en) * | 2004-04-09 | 2005-10-27 | Nippon Menaade Keshohin Kk | Matrix metalloprotease inhibitor |
JP2006028128A (en) * | 2004-07-21 | 2006-02-02 | Nippon Menaade Keshohin Kk | Thrombosis ameliorating agent |
JP2012131754A (en) * | 2010-12-24 | 2012-07-12 | Nippon Menaade Keshohin Kk | Antithrombotic agent |
CN103616339A (en) * | 2013-11-07 | 2014-03-05 | 培力(南宁)药业有限公司 | Detection method for preparation containing ganoderan |
JP2015187176A (en) * | 2015-07-21 | 2015-10-29 | 日本メナード化粧品株式会社 | Antithrombotic agents |
-
1980
- 1980-12-29 JP JP55187752A patent/JPS57112331A/en active Granted
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60184025A (en) * | 1984-03-02 | 1985-09-19 | Toyo Yakushiyoku Kogyo Kk | Polysaccharide, separation and use thereof |
JPS6338325B2 (en) * | 1984-03-02 | 1988-07-29 | Toyo Yakushoku Kogyo Kk | |
JP2005162627A (en) * | 2003-11-28 | 2005-06-23 | Nippon Menaade Keshohin Kk | Medicinal composition of ingredient of ganoderma atrum, ganoderma japonicum, ganoderma sinense or the like |
JP4536360B2 (en) * | 2003-11-28 | 2010-09-01 | 日本メナード化粧品株式会社 | Antithrombotic |
JP2005298391A (en) * | 2004-04-09 | 2005-10-27 | Nippon Menaade Keshohin Kk | Matrix metalloprotease inhibitor |
JP4607484B2 (en) * | 2004-04-09 | 2011-01-05 | 日本メナード化粧品株式会社 | Cancer metastasis inhibitor |
JP2006028128A (en) * | 2004-07-21 | 2006-02-02 | Nippon Menaade Keshohin Kk | Thrombosis ameliorating agent |
JP4643936B2 (en) * | 2004-07-21 | 2011-03-02 | 日本メナード化粧品株式会社 | Thrombosis ameliorating agent |
JP2012131754A (en) * | 2010-12-24 | 2012-07-12 | Nippon Menaade Keshohin Kk | Antithrombotic agent |
CN103616339A (en) * | 2013-11-07 | 2014-03-05 | 培力(南宁)药业有限公司 | Detection method for preparation containing ganoderan |
JP2015187176A (en) * | 2015-07-21 | 2015-10-29 | 日本メナード化粧品株式会社 | Antithrombotic agents |
Also Published As
Publication number | Publication date |
---|---|
JPH0148249B2 (en) | 1989-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS53113008A (en) | Constant rate releasing preparation | |
JPS57193412A (en) | Prevention of prostatic hyperplasia and therapeutical drug | |
JPS57112331A (en) | Medical composition of ganoderma lucidum component | |
JPS5228947A (en) | Oral remedy for hyperlipemia | |
JPS57122085A (en) | Circulatory disease extirpenter and use | |
JPS56128721A (en) | Antiallergic agent | |
JPS57126420A (en) | Drug for digestive organ | |
JPS5795914A (en) | Antithrombin-like drug | |
JPS55122724A (en) | Antidiabetic agent | |
JPS5257319A (en) | Anticeptic treatment of foods | |
JPS55122715A (en) | Antidiabetic agent | |
JPS5585526A (en) | Remedy for allergic disease | |
JPS56115720A (en) | Prophylactic agent for pigling | |
JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
JPS5389671A (en) | Continuous treating apparatus | |
SU1042752A1 (en) | Method of treating chronic urethritis | |
IL82317A0 (en) | 1,4 dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds | |
Mongeau et al. | Propranolol efficacy in essential hypertension in adolescents. | |
JPS55118420A (en) | Preparation of improved vaccine for hooping cough | |
JPS5661993A (en) | Preparation of immune adjusting substance having antitumor action from mycelium belonging to genus peziza vesiculosa | |
JPS5742620A (en) | Novel antiulcer agent | |
JPS55111422A (en) | Antitumorigenic agent | |
JPS5731619A (en) | Improver for liver function | |
JPS51125963A (en) | Biological treatment method of waste water using migration gas-liquid contact members | |
Pereverzev et al. | The role of APUD-system cells and their mediators in the biological effects of adaptogenes |